Using Sorafenib as a Salvage Treatment for Relapsed or Refractory Acute Myeloid Leukemia Carrying FLT3-ITD
Clinical trial NCT03622541 · COMPLETED
Trial details
- NCT number
- NCT03622541
- Sponsor
- The University of Hong Kong
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-15
- Primary completion
- 2019-12-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.